| scholarly article | Q13442814 |
| P2093 | author name string | Shiro Amano | |
| Kenji Inoue | |||
| P2860 | cites work | Importance of tear film instability in dry eye disease in office workers using visual display terminals: the Osaka study. | Q50442111 |
| Regulation of ocular mucin secretion by P2Y2 nucleotide receptors in rabbit and human conjunctiva. | Q50522217 | ||
| Marx line: fluorescein staining line on the inner lid as indicator of meibomian gland function. | Q50735564 | ||
| Increase in tear film lipid layer thickness after instillation of 3% diquafosol ophthalmic solution in healthy human eyes. | Q50760492 | ||
| Meibomian gland dysfunction in patients with Sjögren syndrome. | Q50870035 | ||
| Expression of the P2Y₂ receptor on the rat ocular surface during a 1-year rearing period. | Q51116390 | ||
| Development of Definitive and Reliable Grading Scales for Meibomian Gland Dysfunction. | Q53078417 | ||
| Diagnostic tests in the Sicca syndrome | Q70112003 | ||
| Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial | Q84472814 | ||
| Evaluation of lipid layer thickness measurement of the tear film as a diagnostic tool for Meibomian gland dysfunction | Q86478230 | ||
| Dinucleosidasetetraphosphatase in rat liver and Artemia salina | Q28262180 | ||
| Diquafosol tetrasodium: a novel dry eye therapy | Q35609725 | ||
| Topical diquafosol for patients with obstructive meibomian gland dysfunction | Q36876737 | ||
| Do Cyclosporine A, an IL-1 Receptor Antagonist, Uridine Triphosphate, Rebamipide, and/or Bimatoprost Regulate Human Meibomian Gland Epithelial Cells? | Q37242107 | ||
| Development and validation of the Dry Eye-Related Quality-of-Life Score questionnaire | Q38129252 | ||
| Clinic-Based Study on Meibomian Gland Dysfunction in Japan | Q40316649 | ||
| Nucleotide stimulation of Cl(-) secretion in the pigmented rabbit conjunctiva. | Q41690969 | ||
| Meibomian gland morphology in Japanese infants, children, and adults observed using a mobile pen-shaped infrared meibography device | Q43491991 | ||
| Pharmacology of INS37217 [P(1)-(uridine 5')-P(4)- (2'-deoxycytidine 5')tetraphosphate, tetrasodium salt], a next-generation P2Y(2) receptor agonist for the treatment of cystic fibrosis | Q44106305 | ||
| Localization of ocular P2Y2 receptor gene expression by in situ hybridization | Q44489521 | ||
| Diquafosol elicits increases in net Cl- transport through P2Y2 receptor stimulation in rabbit conjunctiva | Q44797192 | ||
| Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye. | Q45122469 | ||
| Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population | Q47734345 | ||
| Automated Measurement of Tear Film Dynamics and Lipid Layer Thickness for Assessment of Non-Sjögren Dry Eye Syndrome With Meibomian Gland Dysfunction | Q48019648 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 1677-1682 | |
| P577 | publication date | 2017-09-14 | |
| P1433 | published in | Clinical Ophthalmology | Q5133782 |
| P1476 | title | Effect of topical 3% diquafosol sodium on eyes with dry eye disease and meibomian gland dysfunction | |
| P478 | volume | 11 |
| Q93064116 | Effects of Preservative-free 3% Diquafosol in Patients with Pre-existing Dry Eye Disease after Cataract Surgery: A Randomized Clinical Trial |
| Q64899282 | Retrospective Observational Study on Rebamipide Ophthalmic Suspension on Quality of Life of Dry Eye Disease Patients. |
| Q93000534 | Tear film lipid layer increase after diquafosol instillation in dry eye patients with meibomian gland dysfunction: a randomized clinical study |
| Q97524123 | The protective effect of 3% diquafosol on meibomian gland morphology in glaucoma patients treated with prostaglandin analogs: a 12-month follow-up study |
| Q64106481 | Translational Preclinical Pharmacologic Disease Models for Ophthalmic Drug Development |
Search more.